Graves' Disease Remission Study: MycoMeth Combo
NCT06068179
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
205
Enrollment
OTHER
Sponsor class
Conditions
Graves' Disease
Interventions
DRUG:
Mycophenolate Mofetil, Oral, 250 Mg
DRUG:
methimazole, oral, 10mg
Sponsor
The First Affiliated Hospital of Xiamen University